2 Oct 2026, 09:41
Company UpdateMS
ILAISLAND PHARMACEUTICALS LIMITED
Announcement history available from 1 August 2025
Fromto
30 Sept 2026, 11:53
Meetings & Governance—
31 Aug 2026, 09:01
Company UpdateMS
26 Aug 2026, 15:16
Company Administration—
26 Aug 2026, 15:16
Financial Results—
26 Aug 2026, 15:04
Financial ResultsMS
21 Aug 2026, 08:56
Company UpdateMS
13 Aug 2026, 09:21
Meetings & Governance—
12 Aug 2026, 09:35
Securities Administration—
12 Aug 2026, 09:32
Securities Administration—
7 Aug 2026, 08:43
Presentations—
30 July 2026, 09:47
Quarterly ReportsMS
27 July 2026, 09:23
Presentations—
13 July 2026, 16:29
Securities Administration—
13 July 2026, 16:27
Securities Administration—
13 July 2026, 16:21
Securities Administration—
13 July 2026, 16:21
Securities Administration—
13 July 2026, 09:46
Company UpdateMS
8 July 2026, 10:02
PresentationsMS
8 July 2026, 09:00
Securities Administration—
7 July 2026, 09:02
Company UpdateMS
3 July 2026, 12:23
Trading Halt / SuspensionMS
3 July 2026, 12:01
Trading Halt / SuspensionMS
2 July 2026, 09:38
Company UpdateMS
17 June 2026, 08:54
Company UpdateMS
16 June 2026, 09:58
PresentationsMS
11 June 2026, 12:25
Presentations—
11 June 2026, 09:46
PresentationsMS
10 June 2026, 08:53
Company UpdateMS
4 June 2026, 09:03
Company UpdateMS
21 May 2026, 09:25
Company AdministrationMS
19 May 2026, 08:44
Company UpdateMS
28 Apr 2026, 08:30
Securities Administration—
28 Apr 2026, 08:23
Securities Administration—
27 Apr 2026, 09:46
Quarterly ReportsMS
30 Mar 2026, 11:19
Securities Administration—
30 Mar 2026, 11:17
Securities Administration—
23 Mar 2026, 10:29
Securities Administration—
23 Mar 2026, 10:27
Securities Administration—
9 Mar 2026, 09:47
Company UpdateMS
4 Mar 2026, 09:22
Company UpdateMS
2 Mar 2026, 09:37
Trading Halt / SuspensionMS
25 Feb 2026, 16:21
Financial ResultsMS
16 Feb 2026, 08:28
Securities Administration—
16 Feb 2026, 08:21
Securities Administration—
10 Feb 2026, 10:45
ASX QueryMS
5 Feb 2026, 09:57
Presentations—
4 Feb 2026, 09:34
Securities Administration—
4 Feb 2026, 09:34
Capital RaisingMS
4 Feb 2026, 09:29
Company UpdateMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 2 Oct 2026, 09:41 | Galidesivir GMP manufacturing commences | Company Update | MS | 11001 | |
| 30 Sept 2026, 11:53 | Annual General Meeting - Rescheduled Date | Meetings & Governance | — | 08006 | |
| 31 Aug 2026, 09:01 | Pivotal Marburg data secured for Galidesivir FDA pathway | Company Update | MS | 11001 | |
| 26 Aug 2026, 15:16 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 26 Aug 2026, 15:16 | Annual Report to shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 26 Aug 2026, 15:04 | Preliminary Final Report | Financial Results | MS | 03003 | |
| 21 Aug 2026, 08:56 | Island boosts Galidesivir supply as Ebola surges | Company Update | MS | 11001 | |
| 13 Aug 2026, 09:21 | Date of AGM & Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 12 Aug 2026, 09:35 | Cleansing Notice | Securities Administration | — | 06018 | |
| 12 Aug 2026, 09:32 | Application for quotation of securities - ILA | Securities Administration | — | 06020 | |
| 7 Aug 2026, 08:43 | Investor presentation | Presentations | — | 03026 | |
| 30 July 2026, 09:47 | Quarterly Appendix 4C and Activities Report | Quarterly Reports | MS | 19004, 19009 | |
| 27 July 2026, 09:23 | Investor Presentation - TechKnow Invest Roadshow | Presentations | — | 03026 | |
| 13 July 2026, 16:29 | Notification regarding unquoted securities - ILA | Securities Administration | — | 06021 | |
| 13 July 2026, 16:27 | Notification regarding unquoted securities - ILA | Securities Administration | — | 06021 | |
| 13 July 2026, 16:21 | Notification regarding unquoted securities - ILA | Securities Administration | — | 06021 | |
| 13 July 2026, 16:21 | Notification regarding unquoted securities - ILA | Securities Administration | — | 06021 | |
| 13 July 2026, 09:46 | Texas Biomed SOW accelerates pivotal FDA pathway | Company Update | MS | 11001 | |
| 8 July 2026, 10:02 | Investor Presentation - Ebola Clinical Program | Presentations | MS | 03026 | |
| 8 July 2026, 09:00 | Notification of cessation of securities - ILA | Securities Administration | — | 06027 | |
| 7 July 2026, 09:02 | Galidesivir approved for treatment use in in Ebola epidemic | Company Update | MS | 09014, 11001, 14014 | |
| 3 July 2026, 12:23 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 3 July 2026, 12:01 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 2 July 2026, 09:38 | Singapore Patent Expands Island's ISLA 101 Viral Protection | Company Update | MS | 11001 | |
| 17 June 2026, 08:54 | FDA Grants Orphan Designation for Galidesivir in Marburg | Company Update | MS | 11001 | |
| 16 June 2026, 09:58 | Investor Presentation - Asia Dengue Summit | Presentations | MS | 03026 | |
| 11 June 2026, 12:25 | Investor presentation (updated) | Presentations | — | 03026 | |
| 11 June 2026, 09:46 | Investor presentation | Presentations | MS | 03026, 14014 | |
| 10 June 2026, 08:53 | Island Secures USAMRIID Support for Galidesivir Study | Company Update | MS | 11001, 14014 | |
| 4 June 2026, 09:03 | Island Advances Galidesivir GMP Manufacturing for Biodefence | Company Update | MS | 11001 | |
| 21 May 2026, 09:25 | Island Adds Biodefence Leader as Filovirus Risks Escalate | Company Administration | MS | 12008 | |
| 19 May 2026, 08:44 | Island Bolsters US Biodefence Readiness Ahead of Trials | Company Update | MS | 11001 | |
| 28 Apr 2026, 08:30 | Cleansing Notice | Securities Administration | — | 06018 | |
| 28 Apr 2026, 08:23 | Application for quotation of securities - ILA | Securities Administration | — | 06020 | |
| 27 Apr 2026, 09:46 | Quarterly Appendix 4C and Activities Report | Quarterly Reports | MS | 19003, 19008 | |
| 30 Mar 2026, 11:19 | Cleansing Notice | Securities Administration | — | 06018 | |
| 30 Mar 2026, 11:17 | Application for quotation of securities - ILA | Securities Administration | — | 06020 | |
| 23 Mar 2026, 10:29 | Cleansing Notice | Securities Administration | — | 06018 | |
| 23 Mar 2026, 10:27 | Application for quotation of securities - ILA | Securities Administration | — | 06020 | |
| 9 Mar 2026, 09:47 | Antiviral pipeline expansion through strategic collaboration | Company Update | MS | 11001 | |
| 4 Mar 2026, 09:22 | US Government collaboration for Galidesivir development | Company Update | MS | 09014, 11001 | |
| 2 Mar 2026, 09:37 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 25 Feb 2026, 16:21 | Appendix 4D & Half-Year Financial Statements | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 16 Feb 2026, 08:28 | Cleansing Notice | Securities Administration | — | 06018 | |
| 16 Feb 2026, 08:21 | Application for quotation of securities - ILA | Securities Administration | — | 06020 | |
| 10 Feb 2026, 10:45 | Response to ASX Query Letter | ASX Query | MS | 17003 | |
| 5 Feb 2026, 09:57 | Investor presentation | Presentations | — | 03026 | |
| 4 Feb 2026, 09:34 | Proposed issue of securities - ILA | Securities Administration | — | 06013 | |
| 4 Feb 2026, 09:34 | $9m placement to advance US biodefence opportunity | Capital Raising | MS | 06003 | |
| 4 Feb 2026, 09:29 | FDA confirms Galidesivir approval pathway | Company Update | MS | 09014, 11001, 14014 |
1–50 of 102
1 / 3